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Objective: To	identify	factors	associated	with	culture-proven	serious	bacterial	infection	(SBI)	and	
positive	emergency	department	septic	screening	(EDSS)	tests	in	children	with	bronchiolitis	and	to	
identify	factors	associated	with	the	performance	of	EDSS.	
Methods: We	reviewed	an	existing	study	database	of	patients	with	bronchiolitis.	We	defined	a	positive	
EDSS	as	urine	with	≥10	WBC	per	high	power	field	or	cerebrospinal	fluid	(CSF)	with	≥10	WBC	per	high	
power	field	(>25	WBC	in	neonates),	or	if	organisms	were	identified	on	gram	stain.	We	defined	SBI	
as	significant	growth	of	an	accepted	pathogen	in	blood,	urine	or	CSF.	Our	composite	endpoint	was	
positive	if	either	of	these	was	positive.	The	decision	to	perform	testing	was	modeled	using	modified	
Poisson	regression;	the	presence	of	the	combined	outcome	was	modeled	using	logistic	regression	
modified	for	rare	events.	
Results: We	studied	640	children.	Testing	was	performed	in	199/640	(31.1%).	These	tended	to	be	
younger	than	two	months	RR	2.69	(95%	CI	2.11,	3.44),	febrile	RR	2.01	(95%	CI	1.58,	2.55),	more	
dehydrated	RR	1.50	(95%	CI	1.28,	1.75)	and	had	more	severe	chest	wall	retractions	RR	1.54	(95%	CI	
1.22,	1.94).	Only	11/640(1.7%)	had	a	positive	EDSS	or	SBI.	Younger	age	(OR	0.67	per	month;	95%	
CI	0.45,	0.99)	and	a	negative	RSV	antigen	test	(OR	6.22;	95%	CI	1.30,	29.85)	were	associated	with	
the	composite	endpoint.
Conclusion: Testing	was	more	likely	to	be	performed	in	children	younger	than	two	months	of	age,	
and	in	those	who	were	febrile,	dehydrated,	and	had	more	severe	chest	wall	retractions.	A	positive	
EDSS	or	SBI	was	rare	occurring	in	younger	infants	with	non-RSV	bronchiolitis.	
[West	J	Emerg	Med.	2010;	11(1):60-67].
INTRODUCTION
The detection of respiratory syncytial virus (RSV) 
decreases the probability of a concurrent bacterial illness in 
infants with fever without source.1-3 The clinical presentation 
of RSV is highly variable. It causes more than half of all cases 
of bronchiolitis.4,5 Other viruses are responsible for almost all 
of the remainder.4,6-9
Bronchiolitis itself is a clinically recognizable viral 
illness; consequently, a low prevalence of culture-proven 
serious bacterial illness (SBI) would be anticipated.10-12 This 
raises the question whether bronchiolitis caused by RSV 
as distinct from bronchiolitis caused by other viruses has a 
different prevalence of bacterial co-infection and therefore 
warrants a different emergency department (ED) evaluation. Volume XI, no. 1  :  February 2010             61  Western Journal of Emergency Medicine
The primary purpose of this study was to identify those 
clinical factors most likely associated with SBI and positive 
ED screening tests in children with bronchiolitis. The 
secondary purpose was to identify factors associated with 
obtaining these screening tests and cultures. 
METHODS 
Underlying assumptions
We made the following assumptions about emergency 
physicians’ (EP) risk tolerance: (1) a positive screening 
test for SBI would prompt a change in management 
regardless of subsequent outcomes (since these cannot be 
known ahead of time); (2) EPs would not want to miss an 
infant who had a positive culture despite a (false) negative 
screening test. 
   We made the following assailable but unavoidable 
assumptions about bacterial illness in these patients. Firstly, 
we assumed that if both screening tests and cultures were 
negative that SBI was absent. Secondly, we assumed if 
no screening was performed without any adverse clinical 
outcomes three days post-ED visit, then SBI was absent. We 
anticipated that the outcomes we were seeking would be 
sufficiently rare that our primary analysis would require a 
combined endpoint rather than separate analyses of several 
single endpoints. 
Study Design 
Our Institutional Review Board approved this study. 
We conducted a retrospective review using existing patient 
records and an existing database of ED patients prospectively 
enrolled into an RCT over three bronchiolitis seasons.5 
Setting and Population
The parent study was conducted at two centers; this study 
used data only from the primary study site. The primary study 
site was a county teaching hospital ED with an annual census 
of 53,000 (23% children less than 14 years) serving a mixed 
urban, suburban, and rural population. 
Bronchiolitis was defined as clinical evidence of lower 
airway obstruction (physical findings of wheezing and chest 
wall retractions) following an upper respiratory tract infection. 
The eighteenth month of life was chosen as the upper age 
limit. This represents a compromise between competing views 
as to an appropriate definition of the diagnosis.5,10 
Neonate was defined as age up to 28 days. Dehydration 
and retraction severity were each described using scales from 
a validated bronchiolitis severity assessment tool.13 The inter 
rater reliability of these individual variables and that of the 
severity of illness tool been described elsewhere.14 Fever was 
defined as rectal temperature ≥38.0°C.
Patients were enrolled consecutively. Those with 
bronchiolitis so mild as to not require bronchodilator 
treatment and those with illness so severe as to require 
immediate intubation were excluded. These criteria reflect 
the design of the parent study, a randomized controlled trial 
of bronchodilators in bronchiolitis. We restricted this study to 
patients from that study to ensure the quality of data collected. 
Patients who received bronchodilators in the ED prior to 
screening for the parent study were excluded from that study 
and also from this. Although the patients included in this study 
reflect the parent study design, it is difficult to imagine an EP 
prescribing antibiotics in infants with bronchiolitis so mild as 
to not be eligible for the original trial, or withholding them in 
patients intubated for bronchiolitis. 
Patients were recruited between November 1, 2003 and 
May 1, 2006. Potentially eligible children were identified 
by trained research assistants, residents and faculty. 
Diagnosis was made by an attending physician or midlevel 
provider. Clinical findings, including prior antibiotic and 
steroid use, were recorded on a specifically designed data 
collection.Laboratory testing was ordered at the physician’s 
discretion.
Laboratory tests
We performed RSV antigen detection on nasal aspirates 
samples using the BD Directigen™ RSV Test Kit (Becton, 
Dickinson and Company, Franklin Lakes, NJ).
We performed urinalysis and cultures on catheterized 
specimens. Urinalysis was performed with an Iris iQ200 
Automated Urine Microscopy Analyzer (Iris Diagnostics, 
Chatsworth, CA). Urine culture was performed using the 
calibrated-loop method on well-mixed, uncentrifuged 
specimens on blood agar and MacConkey agar plates. Low 
colony count plates (recommended if the child has received 
antibiotics prior to the sample being obtained) were used if 
specified by the physician. Results were reported after 48 
hours of incubation. Cerebrospinal fluid (CSF) specimens 
were processed for protein, glucose, red and white blood cell 
counts (RBC, WBC), gram stain (GS) and cultures. Blood 
cultures were processed using the BacT/ALERT system 
(bioMérieux, Marcy l’Etoile, France), and their results were 
generally available after 48 hours.
Study Protocol
We obtained clinical data from the study database. Testing 
results were obtained from the hospital laboratory database. 
The clinical record was reviewed by first and second authors 
to determine whether positive cultures were treated by the 
physician.
Outcome measures: 
An ED septic screen (EDSS) was considered positive 
if urine or CSF analysis showed ≥10 WBC per high power 
field (>25 WBC in neonates) or organisms were identified 
on gram stain regardless of subsequent culture being positive 
or negative. CSF WBC counts were corrected assuming one 
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additional WBC to be normal for every 500 RBCs present.
We defined culture-proven SBI as a significant growth of 
a known bacterial pathogen in urine (10,000 or more colony-
forming units per milliliter of a single pathogenic organism on 
a catheterized specimen), CSF or blood regardless of initial 
urine or CSF WBC results. When more than one organism 
was detected in a urine culture the specimen was considered 
contaminated. We considered blood cultures contaminated if 
they grew organisms commonly not accepted as pathogens 
(such as coagulase-negative staphylococcus, diphtheroids, and 
alpha- or gamma-hemolytic streptococcus).
We created a composite endpoint comprised of either a 
positive EDSS or a culture-proven SBI, or both. Patients who 
did not have laboratory tests and were alive 72 hours post-ED 
discharge (as assessed by telephone follow-up) were assumed 
not to have had either an SBI or the composite endpoint. In 
cases where both telephone and written follow-up failed, and a 
review of hospital medical records showed no further contact 
with the patient, the county coroner’s records were used to 
determine vital status. 
We did not address the possibility of pneumonia as an SBI 
because of the inability to differentiate a viral from a bacterial 
cause on chest x-ray.
Data analysis
We compared the prevalence of outcomes between RSV-
positive and RSV-negative groups using Fisher’s exact test for 
categorical data. We analyzed the importance of age, gender, 
presence of fever, clinical exam findings, and prior community 
antibiotic use on outcomes using logistic regression 
multivariate analysis. A modified multivariate Poisson 
analysis15 was performed to determine factors associated with 
having an EDSS performed or not performed. We used logistic 
regression modified for rare events to account for biased 
standard logistic regression estimates in the case of a rare 
outcome.16,17 We performed model diagnostics on the standard 
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Table 1.	Demographic	and	clinical	information	by	RSV	status	
RSV	Positive
(N	=	334)
RSV	Negative
(N	=	271)
RSV	Equivocal/Not	Done
(N	=	35)
Mean age, months
(Median , IQR)
Male (%)
5.3
(4.4,	5.6)
193	(57.8)
6.5
(5.0,	6.7)
163	(60.2)
7.4
(7.0,	7.8)
15(42.9)
Premature, (%)
(<37	wks	gestation)
Admission rate, (%)
62	(18.6)
167	(50.0)
52(19.2)
80(30.0)
5	(14.3)
7	(20.0)
Median respiratory rate 45 43 42
Days ill before ED visit Mean
(Median, IQR)
Temp, (°C)
4.8
(3,	3)
37.8
4.1
(3,	3)
37.7
6.0
(3,	6)
37.9
Mean Pulse oximetry, (%) 97 97 98
Febrile, (%)
	38.0°C-39.0	°C	(%) 	78/334	(23.4) 	46/271	(17.0) 7/35	(20.0)
	39.0°C-40.0°C	(%) 24/324	(7.4) 24/271	(8.9)	 3/35	(8.6)
>40°C,	(%) 13/334	(3.9) 9/271	(3.3)	 2/35	(5.7)	
Normal Hydration, % 287/327	(87.8) 232/265	(87.6) 32/33	(97.0)
	5%	Dehydrated,	(%) 27/327	(8.3) 27/265	(10.2) 1/33	(3.0)
10%	Dehydrated,	(%) 12/327	(3.7) 6/265	(2.3) 0/33	(0.0)
15%	Dehydrated,	(%) 1/327	(0.3) 0/265	(0.0) 0/33	(0.0)
Retraction Severity 
None
Mild
Moderate
Severe
	24	(7.8)
	148	(48.2)
	120	(39.1)
	15	(4.9)
	17	(6.8)
	129	(51.2)
	94	(37.3)
	12	(4.8)
	4	(13.3)
	14	(46.7)
	12	(40.0)
	0	(0.0)
Community	antibiotic	use 34/328	(10.5) 31/266	(11.8) 6/35	(17.1)
Steroid use (%) 15/334	(4.5) 10/271	(3.7) 2/35	(5.7)
RSV,	Respiratory	Syncytial	Virus;	IQR,	interquartile range;	ED,	emergency	department.Volume XI, no. 1  :  February 2010             63  Western Journal of Emergency Medicine
logistic regression model as described in other medical 
literature using this technique.18 Tests reached statistical 
significance at p ≤ .05. We used Stata 9.2 statistical software, 
(Statacorp LP, College Station TX), for all analyses.
RESULTS 
Data were available for 640 patients. RSV antigen testing 
was performed in 608 (95%) of these 640. The ED ordered 
RSV testing in 553 cases, the admitting pediatric service 
ordered it in 55. Three hundred thirty-four patients (54.9%) 
tested positive for RSV antigen, 271 (44.6%) tested negative 
and in 3 (0.5%) results were equivocal.
The median age of patients was 4.8 months. Patients’ 
clinical and demographic characteristics are grouped by RSV 
status in Table 1.
ED testing to rule out bacterial illness was performed in 
199/640 (31.1%) of patients. There were differences between 
children in whom physicians did and did not perform testing 
for bacterial illness. Those investigated were more likely to 
be younger than two months RR 2.69 (95% CI 2.11, 3.44), be 
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Table 2.	Details	of	infants	with	a	positive	outcome.
ID AGE RSV Sex Blood Culture Urine 
WBC
units
Urine Culture CSF
WBC
units
Classification 
for Analysis
Comments
7 43	days + M Coag	neg	
staphylococcus
9 Klebsiella 
coag	neg 
staphyloccus
E. faecalis
0 EDSS	-	
SBI	-
Clinician	considered	blood	
culture	significant	and	
treated	but	analyzed	as	
negative.	
2 19	days - M Coag	neg	
staphylococcus
1 No	growth 12 EDSS	-
SBI	-
Treated	initially	as	menin-
gitis.	CSF	Protein	93	but	
analyzed	as	negative
3 23	days + F none 0 Gamma
hemolytic	
streptococcus
0 EDSS	-
SBI	-
	Febrile.	Considered	a	
real	SBI	by	the	treating	
clinician	but	analyzed	as	
negative.	
4 27	days - F none 51 No	growth 0 	EDSS	+
SBI	-
5 35	days - F none 405 E.coli 0 EDSS	+
SBI	+
6 43	days + M Group	B
streptococcus
Not	
done
No	growth 0 EDSS	–
SBI	+
	
1 13	days - M None 0 Contaminant 40 EDSS	+
SBI	-
CSF	culture	negative.	
Analyzed	as	EDSS	only	+	
8 48	days - M none 2 Klebsiella
pneumoniae
0 EDSS-
SBI+
SBI	positive	urine	culture.	
Subsequently	had	two	
more	UTIs.
9 51	days - M none 46 Candida
glabrata
0 EDSS+
SBI+
C. glabrata	considered	
significant	by	clinician.	
10 59	days - F none 12 Not	done 0 EDSS+
SBI-
11 56	days	 - M none 5 E.coli 0 EDSS-
SBI+
SBI	Positive	urine	culture.
12 87	days	 + F Coag	neg	
staphylococcus
21 Coag	neg	
staphyloccus
0 EDSS+	SBI- Clinician	considered	
cultures	significant	and	
treated	but	analyzed	as	
EDSS	+	SBI-
13 4	months
12	days
- M Not	Done 12 Not	done 0 EDSS+
SBI-
14 7	months
	3	days	
- F Staphylococcus 
aureus
Not	
done
Not	done 0 EDSS-
SBI	+
RSV,	Respiratory	Syncytial	Virus;	WBC,	white	blood	count;	CSF,	cerebrospinal	fluid;	EDSS,	emergency	department	septic	screening;	
SBI,	serious	bacterial	infection.Western Journal of Emergency Medicine            64  Volume XI, no. 1  :  February 2010
febrile RR 2.01 (95% CI 1.58, 2.55), be more dehydrated RR 
1.50 (95% CI 1.28, 1.75), and have more severe chest wall 
retractions RR 1.54 (95% CI 1.22, 1.94). RSV antigen results 
did not dissuade physicians from testing, RR 0.82 (95%CI 
0.65, 1.04).
Although 14 patients were treated as having a positive 
EDSS or SBI by their treating physicians, our study 
definitions led us to discount three cases. These are shown in 
Table 2. Using study definitions, the combined endpoint of a 
positive septic screen, culture-proven SBI, or both occurred 
in 2/334 (0.6%, 95% CI 0.1% to 2.1%) and 9 of 271 (3.3%, 
95% CI 1.5% to 6.2%) in RSV and non-RSV bronchiolitis, 
respectively (two sided Fisher’s exact, p=.02).
Using logistic regression modified for rare events, 
younger age (OR 0.67 per month; 95% CI 0.45, 0.99) and 
a negative RSV antigen test (OR 6.22; 95% CI 1.30, 29.85) 
were associated with the composite endpoint. These results are 
presented graphically in the Figure. Using ordinary logistic 
regression, age (OR 0.63 per month; 95% CI 0.43, 0.94) and a 
negative RSV antigen test (OR 7.77; 95%CI 1.61, 37.56) were 
associated with the primary or composite endpoint. The results 
were similar (age OR 0.57, RSV negative OR 4.81) when we 
analyzed the treating physicians’ clinical impressions rather 
than study definitions of which infants had a positive EDSS or 
SBI. 
The results were similar for the individual components 
(EDSS and SBI) of the endpoint. The prevalence of a positive 
EDSS was 7/605(1.1% 95% CI 0.4%, 2.2%); 1 of 334 (0.3%, 
95% CI 0.0%, 1.7%) in the RSV group and 6 of 271 (2.2%, 
95% CI 0.8%, 4.8%) in non-RSV bronchiolitis (two sided 
Fisher’s exact, p=.049). Prevalence of a culture-proven SBI 
was 6/640 (0.9% 95% CI 0.3% to 2.0%). One of 334 (0.3%; 
95% CI 0.0% to 1.7%) had RSV-positive and 5 of 271 (1.8%, 
95% CI 0.06% to 4.3%) had RSV-negative bronchiolitis, (two-
sided Fishers exact p=0.095).
Of the individual EDSS components, blood cultures were 
the most frequently obtained. However, urinary studies were 
the most likely to yield positive findings. Urine microscopy 
was performed in 95/640 (14.8%), urine cultures in 71/640 
(11.0%), blood cultures in 183/640 (28.6%) and lumbar 
punctures in 10/640 (1.5%). Six out of 95 (6.3%) patients had 
>10 WBC in on urine microscopy, 2/10 (20%) had >10 WBC 
(corrected) in the CSF, and 7/71 (9.9%) had a positive urine 
culture. Twenty-one of 183 blood cultures grew organisms; of 
these, only two were recognized pathogens. 
Prior antibiotic use did not seem to alter outcome; low 
colony count plates were not used in some children who had 
had prior antibiotics. The prevalence of SBI and EDSS in each 
age group is shown in Table 3.
DISCUSSION
In children up to their eighteenth month of life with 
bronchiolitis, an EDSS was more likely to be performed in 
those who were less than two months old, febrile, dehydrated, 
and had more severe chest wall retractions; in short, those who 
appeared sicker. This evaluation was more likely to be positive 
in those who were younger and had a negative RSV antigen 
test. Once the decision to screen was made, neither fever nor 
the height of the fever was associated with SBI or positive 
EDSS. The paucity of positive outcomes despite relatively 
large sample size resulted in broad confidence intervals for our 
estimates of these effects. 
Studies of febrile children have shown that when a 
viral etiology can be demonstrated, typically by RSV or 
influenza antigen testing, concurrent bacterial infection is 
rare.1-3,11,19 Despite this, RSV status did not significantly 
affect the decision to obtain these tests in our study (RR 
0.82 95% CI 0.65-1.04). Perhaps with larger numbers this 
Table 3.	Prevalence	of	Respiratory	Syncytial	Virus	(RSV)	and	
serious	bacterial	infection	(SBI)	or	emergency	department	septic	
screening	(EDSS)	by	age.	
Age
(months)
RSV
positive 
(%)*
SBI
(%)
 EDSS
(%)
Combined
(%)
	<1 31/41	(76) 0/43	(0) 2/43	(4.7) 2/43	(4.7)
1-2 57/95	(60) 5/96	(5.2) 3/96	(3.1) 6/96	(6.3)
2-3 46/76	(61) 0/80	(0) 1/80	(1.3) 1/80	(1.3)
3-4 18/50	(36) 0/52	(0) 0/52	(0) 0/52	(0)
4-5 32/55	(58) 0/60	(0) 1/60	(1.7) 1/60	(1.7)
5-6 33/54	(61) 0/57	(0) 0/57	(0) 0/57	(0)
6+ 117/234	(50) 1/252	(0) 0/252	(0) 1/252	(0.4)
Total 334/605	(52) 6/640	(0.9) 7/640	(1.1) 11/640	(1.7)
*Excludes	cases	where	RSV	testing	was	equivocal	or	not	per-
formed.
Figure. Predicted	probability	of	a	positive	emergency	department	
septic	screening	or	serious	bacterial	infection	(SBI)	by	age	and	
respiratory	syncytial	virus	(RSV)	testing	results.
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trend would have reached significance. Similarly, in the 
presence of a recognizable viral illness concurrent bacterial 
infection is also unlikely.11 We anticipated, and found, very 
low rates of culture- proven bacterial illness (0.9%) or EDSS 
(1.1%) in infants with bronchiolitis. One might reasonably 
expect, therefore, that RSV antigen testing would add little 
information in the risk stratification of these children. But it 
did, with a negative RSV test increasing the odds of EDSS or 
SBI by 6.22.
Why the prevalence of either a positive EDSS or SBI 
should differ in RSV as distinct from non-RSV bronchiolitis is 
a matter of conjecture. Although clinically indistinguishable, 
the inflammatory profile of RSV bronchiolitis differs from that 
of other viruses.20-23 
A weakness in this study is that EDSS was variable in 
its components. Some children had blood, CSF and urine 
cultured, and some, typically older infants, only had urine 
cultured. This is inherent in the retrospective use of even 
prospectively collected research data. Even if a purely 
prospective design were employed, it would not be ethical to 
subject children to investigations that the treating clinician did 
not believe were indicated. 
A related limitation is the possibility of a missed SBI in 
those not screened and who did not have an adverse outcome 
within three days of enrollment in the parent study. The 
most likely source in these cases would be urinary, and the 
most likely pathogen Escherichia coli, (E. coli). Where the 
infection is confined to the urinary tract it is possible that 
some infants would have cleared the infection spontaneously. 
Sepsis in conjunction with UTI occurred in 31% of neonates, 
21% of infants aged 1 to 2 months, 14% of those aged two to 
three months, and 5.5% of infants over three months of age in 
one series.24 Mortality rates as high as 45% to 73%, depending 
on the underlying prognosis, have been reported in children 
growing E. coli in blood cultures.25 As there was only one 
death within 30 days of enrollment (in a severely co-morbid 
ex-premature infant), a clinically important miss rate for SBI 
in unscreened patients seems unlikely.
Another limitation is the use of RSV antigen rather than 
PCR testing. The sensitivity and specificity of the test we used 
is modest, 78 % and 67% respectively.26 Whether and how 
PCR testing would have changed our results is speculative. 
We chose our combined endpoint as the primary outcome 
for several reasons. Culture- negative SBI can occur, with 
diagnosis hinging on screening tests and clinical judgment. 
Our necessarily practical definition of EDSS in this study 
included only tests with a turnaround time short enough to 
impact ED management. Dropping “screen positive culture 
negative” cases does not help an EP who cannot know 
beforehand what cultures will grow. 
Including screening tests alone would be incomplete. 
Although infants with urinary WBC<10 are less likely to 
have a urinary tract infection,27,28 culturing is nonetheless 
recommended for all urine specimens obtained in this age 
group.29 While CSF pleocytosis is suggestive, its absence 
in a neonate does not preclude meningitis.30 Consequently, 
we felt that neither culture nor screening tests alone were a 
satisfactory outcome for emergency medicine.
Finally, when studying rare events, using a sensible 
combined outcome measure may allow insights to be obtained 
with smaller sample sizes than would otherwise be possible. 
The rarity of our outcome means that despite a sample size of 
640 patients our confidence intervals are wide.     
Our study definitions sometimes conflicted with the 
treating physicians’ clinical impression of a coexisting 
bacterial illness. Two neonates who were treated based on 
CSF results were ultimately felt not to have an SBI. We 
categorized one of these cases as having a positive EDSS 
but negative SBI. One case was treated by the clinician as 
having a real UTI based on urine culture of gamma hemolytic 
streptococcus. We analyzed a case of Candida glabrata as 
having an EDSS and SBI in one patient who had pyuria. 
Though C. glabrata is often nosocomially acquired, it can 
be considered a non-trivial finding; this patient was treated.31 
Some have questioned whether urinary bacterial colony 
counts less than 50,000 in the presence of low urine WBC 
are significant. We had only one case where this may have 
been an issue; however, this infant has had two subsequent 
UTIs. While reluctant to discount the judgment of the treating 
pediatrician, we felt obliged to analyze the data according to 
our study definitions. Reassuringly, when we analyzed the data 
based on the physicians’ clinical impressions the results were 
similar. 
We were surprised that community antibiotic usage did 
not appear to affect the results. This may in part be because of 
the low prevalence of their use (11%). We were also surprised 
that blood cultures were ordered more frequently than urine 
cultures. They appear to have been ordered reflexively as part 
of the admission process in some cases. 
Our overall prevalence of SBI was lower than some 
previous studies, which report a prevalence of SBI in 
bronchiolitis of 11.4%.1 In RSV bronchiolitis specifically, 
the prevalence rates range from none to 7.0 %.1,32 Children 
with RSV negative bronchiolitis have also been found by 
most though not all others to have a higher prevalence of 
SBI.1,34-36 These studies excluded afebrile infants. We found 
that while the presence of fever influenced the decision to 
work up an infant, once that decision was made, neither 
the presence nor height of the fever was associated with 
a concurrent bacterial illness. Had we excluded infants 
who were afebrile on presentation we would not have been 
able to demonstrate this point. This approach also allowed 
us to capture the practice of experienced clinicians who 
occasionally perform an EDSS in infants without a fever 
yet look unwell. 
Unlike prior work2,31,34-36we included children older than 
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three months of age; this allowed us to prove the importance 
of age as a predictor of concurrent bacterial infection. 
There are some differences between our findings and 
those of others that bear examination. In Liebelt et al 211 
infants aged 90 days or younger with clinical bronchiolitis, no 
case of SBI was found. Of note, 82% of that study’s patients 
had RSV-positive bronchiolitis.33 Given that SBI is more 
likely in RSV negative patients and the CIs for 0/38 overlap 
with our findings, this apparent difference is likely artifactual. 
Antonow et al studied 282 infants less than two months of 
age with clinical bronchiolitis and found a SBI prevalence 
of 1.8%. In that study two-thirds of patients were febrile and 
RSV rate was 83 % (34). In our study, 32% were febrile on 
ED presentation (42% febrile in Liebelt and 65% in Antonow) 
and 55% were RSV-positive. 
Most children, even the very young, will have neither a 
positive EDSS nor an SBI. Among those who do, a UTI is 
the most common diagnosis.1,2,19,32,36 For individual patients, 
clinical judgment, which may be more cost effective than 
using “clinical rules,”37 remains necessary. This study provides 
a measure of the underlying prevalence to help inform 
that judgment. We have not attempted to provide specific 
thresholds at which EDSS may be withheld. Instead we 
have provided our results in a way that we believe informs 
individual physicians’ risk tolerance for what is a rare but 
important outcome.
Future work establishing the prevalence of concurrent 
bacterial lung infection in children with bronchiolitis is 
needed.
CONCLUSION
In those children with bronchiolitis in whom ED testing 
for bacterial illness was performed, younger age and a 
negative RSV antigen test was associated with a positive 
EDSS or SBI.
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